1. Enhanced Isolation of Fetal Nucleated Red Blood Cells by Enythrocyte-Leukocyte Hybrid Membrane-Coated Magnetic Nanoparticles for Noninvasive Pregnant Diagnostics
- Author
-
Zixiang Wang, Lin Cheng, Yuanzhen Zhang, Xiaoyun Wei, Lei Liao, Yue Sun, Xing-Zhong Zhao, and Bo Cai
- Subjects
Erythrocytes ,Current cell ,Surface Properties ,Cell ,010402 general chemistry ,01 natural sciences ,Chromosomes ,Analytical Chemistry ,Andrology ,Fetus ,Fetal cell ,Pregnancy ,Gestational Weeks ,Leukocytes ,medicine ,Humans ,Particle Size ,Magnetite Nanoparticles ,In Situ Hybridization, Fluorescence ,Chemistry ,Cell Membrane ,010401 analytical chemistry ,Nucleated Red Blood Cell ,Aneuploidy ,Peripheral blood ,0104 chemical sciences ,medicine.anatomical_structure ,Membrane ,Female - Abstract
Fetal nucleated red blood cells (fNRBCs) in maternal peripheral blood containing the whole genetic information of the fetus may serve for noninvasive pregnant diagnostics (NIPD). However, the fetal cell-based NIPD is seriously limited by the poor purity of the isolated fNRBCs. Recently, the biomimetic cell membrane-camouflaged nanoparticles containing outstanding features have been widely used to detect and isolate rare cells from the peripheral blood samples. In this work, enythrocyte (RBC) and leukocyte (WBC) membranes are fused and coated onto magnet nanoparticles and then modified with anti-CD147 to isolate fNRBCs from the maternal peripheral blood with significant efficiency (∼90%) and purity (∼87%) in simulated spiked blood samples. Further, fNRBCs were isolated and identified from a series of maternal peripheral blood samples coming from pregnant women of 11-13 gestational weeks, and different chromosomal aneuploidies were diagnosed using fNRBCs isolated from maternal blood in early pregnancy. Our strategy may offer additional opportunity to overcome the limitations of current cell-based NIPD platforms.
- Published
- 2020